NCT02431091View on ClinicalTrials.gov

Evaluation of the Role of OCT in the Detection of HIV-associated Neurocognitive Disorder

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
AIDS-Related Dementia Complex
Interventions
OTHER

Optical Coherence Tomography

Optical Coherence Tomography provides a non invasive evaluation of the thickness of different layers of the retina

Trial Locations (1)

1000

Hopital St Pierre, Brussels

All Listed Sponsors
collaborator

Fonds iris-Recherche, Fondation Roi Baudouin, Belgium

UNKNOWN

lead

Centre Hospitalier Universitaire Saint Pierre

OTHER

NCT02431091 - Evaluation of the Role of OCT in the Detection of HIV-associated Neurocognitive Disorder | Biotech Hunter | Biotech Hunter